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Cancer registries are a vital part of the national cancer effort to cut United States cancer
mortality rates in half by the year 2000. Registries provide the data to focus programs and
monitor progress. Success in meeting the year 2000 goal will require aggressive attention to the
opportunities for prevention, early detection, treatment, and applied cancer control research, all
ofwhich complement the current emphasis on basic research.
"The cancer registry is an essential part of any rational programme of
cancer control benefitting both the individual and the society in which he
lives."
-C.S. Muir
1984 [1]
The National Cancer Institute recently set a goal: to cut cancer mortality rates in
half by the year 2000 [2]. How do we do this-how, using current knowledge, do we
reduce the morbidity and mortality due to cancer? To achieve this goal requires the
aggressive and widespread application of state-of-the-art methods for cancer preven-
tion, early detection, and treatment. It requires the use of cancer registries to focus
programs and monitor progress. And it requires that health scientists and health
practitioners work as hard in applying current knowledge for our entire population-
including research on applications-as they do on uncovering new knowledge and
treating individual patients.
Thus, the National Cancer Institute (NCI) is currently expanding and accelerating
the application of its research and the development of its resources. An essential
component of the national cancer control effort is a comprehensive information base.
This information base or, as we term it, cancer control surveillance system, incorpo-
rates data components within NCI and elsewhere within the federal government, as
well as in state and local governments and the health care industry. As this system
comes into full operation, it will be used to track and evaluate national cancer control
efforts and to help give overall guidance to NCI's cancer control program. The
program is hierarchically structured, with activities being carried out at national,
regional, and local levels; however, in order to achieve the year 2000 goal, efforts at all
levels must be coordinated and implemented cooperatively. Providing the appropriate
information is the goal ofthe cancer control surveillance system.
The most important element within the cancer control surveillance system is the
network of cancer registries-hospital, local, regional, national-which has been
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developed across the United States, in part supported by NCI. Population-based
cancer registries, i.e., those which register information on every newly diagnosed
cancer in a defined geographic area during a specified time period, have been
responsible for tracking cancer incidence and mortality. All cancer registries-
whether or not population-based-that follow patients from diagnosis through death
are useful in establishing survival patterns and for helping to profile cancer screening
and treatment practices. However, a challenge now before the experienced cancer
registries is to analyze and transmit more effectively the information being collected.
Such information should be disseminated to those who can makechanges in the cancer
control system: public health professionals and policy makers, health care profession-
als, and the general public. Another challenge is to assist emerging registries with
methodology and technology to improve the quality ofthe information.
This paper addresses the emerging role of cancer registries in cancer control,
describing only a small portion of their potential. Our particular focus is NCI's
nationwide cancer registry system, the Surveillance, Epidemiology and End Results
(SEER) Program, its growth, its uses, and its relationship to the new cancer control
surveillance system and to the year 2000 objectives.
THE HISTORY
The SEER Program is actually a product of two earlier NCI programs: a series of
three National Cancer Surveys and the End Results Program. The National Cancer
Surveys conducted in 1937-39, 1947-48, and 1969-71 gave the first profiles ofcancer
incidence in selected areas ofthe United States [3,4,5]. The End Results Program was
conducted continuously from 1950 through 1973. At the conclusion ofthese programs
it was decided by NCI staff, on the advice ofexperts from across the United States and
Europe, to develop an ongoing cancer registry system that would provide a national
profile ofcancer incidence and survival.
Participants in the SEER Program have been selected on the basis oftheir ability to
operate and maintain a population-based cancer reporting system and for the unique
population subgroups that each of them offers. From eight participants in 1973, the
program has grown to eleven today. Although SEER areas are not randomly selected,
analysis of cancer mortality data from SEER shows a remarkable similarity to
national data. The NCI believes that the cancer experience of the composite SEER
population reflects that ofthe nation as a whole.
The traditional goals of the SEER Program have been to: (1) determine cancer
incidence levels in the United States and selected geographic areas and monitor their
trends; (2) determine the cancer survival experience of patients diagnosed in selected
geographic areas and monitor their trends with respect to the form ofcancer, extent of
disease, therapy, and other parameters of prognostic importance (i.e., demographic
and socioeconomic characteristics); (3) identify cancer etiologic factors by conducting
special studies which disclose population groups at high or low cancer risks; (4) identify
factors related to patient survival through special studies ofreferral patterns, diagnos-
tic procedures, treatment methods, and other aspects ofmedical care; and (5) promote
specialty training in epidemiology, biostatistics, and tumor registry methodology,
operation, and management.
The network ofSEER registries has helped to illuminatedifferences in the reporting
of cancer experience ofdifferent population groups. For example, mainly from SEER
data, we know that in the United States black males have a higher risk of developing
562CANCER REGISTRIES IN CANCER CONTROL
cancer than do white males, particularly cancers of the lung and prostate gland, while
black females have a slightly lower risk than white females [6]. Furthermore, for
almost every cancer site, black patients have a poorer survival experience than do white
patients, even when considering stage of disease at the time of diagnosis [7]. In
addition, the continuous monitoring ofcancer by the SEER Program has enabled us to
determine, early, that the incidence of lung cancer among males is beginning to be
reversed, the age-adjusted incidence oflung cancer among white males having declined
from 82.7 per 100,000 in 1982 to 79.3 in 1983 [8].
Incidence or death registration information often has been used to uncover etiologic
leads. To take just one of many examples, leads about diet in the etiology of breast
cancer have been suggested by international correlations [9], migrating population
studies [10], and time trend analyses [11]. Extensions of these observational analyses
to include field studies containing epidemiological, laboratory, and clinical measure-
ment may add strength to the evidence. Such an extension would be particularly
relevant in the above example, since the imprecision of dietary assessment methods
[12] limits the usefulness ofthe usual case-control epidemiologic studies. Thus, in some
instances, scientists using registries may have the opportunity to take advantage of the
wider differences found in diet across populations than the more limited differences
often found within populations.
These uses of SEER registry data have been important in cancer control, yet SEER
and non-SEER cancer registries can do more to provide a planning and evaluation base
for cancer control activities. This potential is one ofthe major reasons for NCI's efforts
to develop a cancer control surveillance system. Furthermore, the attitude of the
registry staff is important in utilizing the registry as a surveillance system: an attitude
that a crucial part of their responsibility is research into public health applications of
the data as well as the provision of leadership in the implementation of those
applications. Particularly in respect to etiology and prevention, investigators in the past
have been satisfied with bringing their work only to the point of publishing a
manuscript on etiology. Now enough is known that there are some opportunities to go
further, to follow through with applied research and prevention. It should be no more
acceptable in prevention to drop the work after uncovering an etiologic lead than it is in
treatment, after making the diagnosis, to walk away from the patient thinking that the
problem has been taken care of.
THE CANCER CONTROL SURVEILLANCE SYSTEM
In addition to specific cancer registries, the United States has a wealth of
information resources that can be used to help control cancer. In the past these
resources were rarely used for cancer control purposes and, thus, they did not provide
information to the cancer control system where it was needed. The new emphasis on
cancer control and the setting of a national goal to reduce mortality by 50 percent by
the year 2000 requires the full use of existing resources and the development of new
resources. A key component ofthis initiative is the morecomplete useofdata sources in
a systematic way. Thesedata resources in the aggregate are referred toas the National
Cancer Control Surveillance System. Further planning for this system, including the
use ofavailable data in non-SEER areas, is under way.
NCI is currently in the process ofintegrating the various pieces ofthis system. As a
first step, NCI has brought the SEER Program administratively closer to cancer
control program planning and activities. Following a recent reorganization of the
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cancer control effort at NCI, SEER was moved to the Division of Cancer Prevention
and Control. While not lessening the important role for SEER in studies of etiology,
this change has placed the program that provides the primary measures of cancer
control progress as close as possible to the NCI staff who are primarily involved in
cancer control. Thus, as with any registry, SEER is part of a program. We think that
any registry-hospital, local, regional, or national-must devote at least as much
resources, time, and talent to its use for research and control purposes as it does to data
acquisition, computerization, and publication of annual reports. Otherwise, it is
doubtful that the registry investment is being optimally used.
Plans are under way at NCI to make use of other tracking resources, including
population-based cancer registries and hospital-based cancer registries outside SEER.
Outside NCI a number ofdata systems exist that can be used to produce the indicators
needed-for example, those of the National Center for Health Statistics (NCHS).
NCHS currently has two data systems which can be used to monitor cancer mortality.
Each year data tapes are available from NCHS on all deaths in the United States.
These are used to monitor trends in mortality from specific cancers over time and thus
form the core for monitoring progress toward achieving theyear 2000goal. In addition,
NCHS has established the National Death Index (NDI), which allows researchers to
determine through a centralized system of records whether a given person has died
[13]. The NDI is particularly useful for following large groups ofpersons to determine
their survival.
The role of the surveillance system is to track cancer and to evaluate the impact of
cancer control activities (prevention, screening, and treatment). Clearly, the scope of
the surveillance system depends on the "lens" used to view the system. At the NCI, we
are charged with viewing the system with a "wide angle lens," necessarily taking a
broad view of the cancer system. As geographic areas become smaller, the persons,
groups, and agencies responsible for cancer control must necessarily use a lens with a
narrower field ofview. Thus, the surveillance system is, in fact, a nested set ofsystems
ranging from the system used to monitor cancer at the hospital or clinic level to that at
the regional and national level.
Local registries have an important role to play within the cancer control surveillance
system. Their data can serve as the basis for local planning efforts. In addition, they
can relate to SEER by sharing information and comparison of local data to the
national picture. An example will show the importance of state or local cancer control
programs to follow through on leads from cancer surveillance. Recently, theSaturday
Evening Post conducted a survey on cancer prevention [14]. In spite of the strong
evidence on efficacy of breast cancer screening by mammography plus physician
examination, only 15 percent of women over 50 are receiving annual mammograms.
Most surprising is that 65 percent said their physicians have never recommended the
exams! This certainly suggests a physician education need and perhaps a need to
reorder reimbursement incentives.
FUTURE PLANS
Despite limited financial resources, NCI is planning efforts to work with registries
across the country to enable them to contrast and compare their information as well as
their data-gathering procedures and quality control methods with those of the SEER
Program. By fostering such comparisons in cooperative ventures, the quality of the
information on cancer surveillance throughout the United States will be improved. A
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method now being explored is to establish a professional association ofcancer registries
in the United States under whose mandate the above activities would take place. All
population-based registries would be eligible to become a part ofthis association and to
submit data on a periodic basis for inclusion in a monograph detailing cancer incidence
in the United States.
Information is only useful ifit is applied. Cancer registry information can be useful
in cancer control planning. For example, the information in a cancer registry and allied
information from other sources can be used to outline resources available in caring for
cancer patients. Moreover, using the registry as a planning base, the future need for
resources can also be estimated. Still another use of registry data related to cancer
control planning is assessing the need for and the extent of screening programs. This
might be done through the stage distribution of, for example, breast cancer, which
could be compared with information reflecting a national perspective or from the
clinical trials, reflecting the state of the art. If too many of the cases are found to be
detected in the late stage of the disease, the fact would indicate that the screening
programs are not functioning effectively. In addition, the information in the registry
might be useful to tumor boards as they assess the quality ofcancer care treatment.
In future data collection activities, registries need to be mindful of the changing
health care system and will need to adapt their procedures accordingly where changes
in delivery are anticipated. For example, the advent of Disease Related Groups will
mean that certain types of cancer are not treated in hospitals, and it is possible that
central pathology laboratories will not be involved in the diagnosis. This might be
especially true for the diagnosis and treatment of melanomas. Recent data from the
SEER Program indicate that the incidence of melanoma is decreasing [15]. This may
in fact be due to the detection of fewer cases by the registry because ofchanges in the
way in which the disease is diagnosed and treated.
Thus, one of the most important roles for the NCI in cancer surveillance is in the
assurance of quality data in terms of both accuracy and completeness. Certainly, the
information in the SEER Program must be of the highest quality, and the methods
used to assure that quality should serve as a model for other registries. The NCI is now
considering ways in which the surveillance methods, as practiced by NCI, can be made
as widely available as possible to others.
In conclusion, we at NCI would be very pleased to receive suggestions as to the form
and substance of cancer control surveillance and are committed to work toward
making the nation's cancer control surveillance system as effective a tool as possible.
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